Posts Categorized: MS News

Government advice changes – what does it mean for people with MS?

Last Monday the Government relaxed some of the coronavirus restrictions in what some have dubbed ‘Freedom Day’. But what does that mean for people with MS? “Wear a mask – don’t wear a mask”“Keep two metres from others – social distancing no longer applies”“It’s freedom day – proceed with caution.” If you’re feeling confused by… Read more »

New fatigue guide from the MS International Federation

The MS International Federation’s (MSIF) International Resource Group, from MS Australia, MS Society UK and ARSEP Foundation resources have put together a new guide about MS fatigue.  MS fatigue is one of the most common MS symptoms and one of the hardest to manage.  MS fatigue is not only difficult to define but it is an… Read more »


Source MS Trust: Researchers wanted to find out if there are hidden patterns in MRI brainscans taken over time that would better identify biological differences in MS activity anddetect progression earlier.The study in briefMS is divided into four subtypes: clinically isolated syndrome, relapsing remitting,primary and secondary progressive MS and are used to guide the timing… Read more »

Machine learning identifies new subtypes of MS from MRI scans

The study in brief MS is divided into four subtypes: clinically isolated syndrome, relapsing remitting, primary and secondary progressive MS and are used to guide the timing and choice of treatments. However, these subtypes are based on observed symptoms, such as relapses and disability which can be difficult to measure and may not reflect the… Read more »

MS Society have launched their new forum

Over the last few years, the MS Society has been asking for feedback on how they can improve our forum. This is to make sure they can give you the best experience possible. Thanks to your feedback, they have been able to create the perfect space to support, share, and connect with like-minded people in the MS community.  Read on.

Introducing Octopus – the world’s first multi-arm, multi-stage trial for MS

There are now over a dozen licensed disease modifying therapies (DMTs) for people with relapsing MS, and some emerging for early active progressive MS. But to help people at every stage of MS, we need to stop MS from progressing. Currently, all available DMTs target the immune system. To truly stop MS getting worse, we also need treatments… Read more »

Oxford-AstraZeneca vaccine: Under 30 and live with someone with MS?

On 7 April, the government vaccine advisers (the JCVI) announced new advice for people aged 18-30 who don’t have an underlying condition (such as MS). This could include family, partners or carers of people with MS.  If these people are going for their first jab, they should be offered an alternative to the Oxford-AstraZeneca vaccine, when possible.  This is… Read more »

Ofatumumab licensed for active relapsing-remitting MS in UK

Ofatumumab is a disease-modifying therapy (DMT) that works by targeting a type of immune cell called a B cell.  It is the first self-administered B-cell targeting therapy to be licensed in the UK. After initial guidance from a healthcare professional, ofatumumab can be self-injected at home. The licence is based on the results of two Phase III clinical trials, called… Read more »

UK to test existing drugs as treatment for MS in world-first trial

Doctors in the UK are to launch a world-first clinical trial to assess whether drugs already on the market can prevent multiple sclerosis (MS) from worsening over time and even reverse the disabilities it causes. The groundbreaking Octopus trial, so named because of its various arms, will allow researchers to investigate the potential benefits of… Read more »